Platelet Aggregation Prasugrel-upstream Therapy for NSTEMI without Benefit

被引：0
|
作者：
Feldmann, Christoph
机构：
来源：
AKTUELLE KARDIOLOGIE | 2014年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [1] Factors Affecting Residual Platelet Aggregation in Prasugrel Treated Patients
    Alexopoulos, Dimitrios
    Xanthopoulou, Ioanna
    Perperis, Angelos
    Siapika, Argyro
    Stavrou, Katerina
    Tsoni, Evropi
    Davlouros, Periklis
    Hahalis, George
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (28) : 5121 - 5126
  • [2] The effects of major in vivo metabolites of prasugrel on human platelet aggregation
    Sugidachi, A.
    Niitsu, Y.
    Ogawa, T.
    Jakubowski, J. A.
    Hasegawa, M.
    Hashimoto, M.
    Hagihara, K.
    Kurihara, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 349 - 349
  • [3] The influence of baseline platelet aggregation response on subsequent inhibition of aggregation achieved with clopidogrel or prasugrel
    Jakubowski, JA
    Weerakkody, GJ
    Winters, KJ
    Brandt, JT
    Naganuma, H
    Wallentin, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 378A - 379A
  • [4] Inhibition Of Platelet Aggregation With Prasugrel And Clopidogrel: An Integrated Analysis In 750 Subjects
    Li, Grace Y.
    Ni, Lan
    Brandt, John T.
    Small, David S.
    Payne, Christopher D.
    Ernest, C. Steven
    Rohatagi, Shashank
    Farid, Nagy A.
    Jakubowski, Joseph A.
    Winters, Kenneth J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 76I - 76I
  • [5] Inhibition of platelet aggregation with prasugrel and clopidogrel: An integrated analysis in 846 subjects
    Li, Ying G.
    Ni, Lan
    Brandt, John T.
    Small, David S.
    Payne, Christopher D.
    Ernest, C. Steven, II
    Rohatagi, Shashank
    Farid, Nagy A.
    Jakubowski, Joseph A.
    Winters, Kenneth J.
    PLATELETS, 2009, 20 (05) : 316 - 327
  • [6] Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization The TRILOGY ACS Platelet Function Substudy
    Gurbel, Paul A.
    Erlinge, David
    Ohman, E. Magnus
    Neely, Benjamin
    Neely, Megan
    Goodman, Shaun G.
    Huber, Kurt
    Chan, Mark Y.
    Cornel, Jan H.
    Brown, Eileen
    Zhou, Chunmei
    Jakubowski, Joseph A.
    White, Harvey D.
    Fox, Keith A. A.
    Prabhakaran, Dorairaj
    Armstrong, Paul W.
    Tantry, Udaya S.
    Roe, Matthew T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (17): : 1785 - 1794
  • [7] Entity of inhibition of platelet aggregation and clinical events: new evidence obtained with prasugrel
    Abbate, Rosanna
    Crea, Filippo
    De Servi, Stefano
    Filippi, Erica
    Gensini, Gian Franco
    Golino, Paolo
    Savonitto, Stefano
    GIORNALE ITALIANO DI CARDIOLOGIA, 2010, 11 (02) : 127 - 137
  • [8] Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
    Adamski, Piotr
    Baranska, Malwina
    Ostrowska, Malgorzata
    Kuliczkowski, Wiktor
    Buszko, Katarzyna
    Koscielska-Kasprzak, Katarzyna
    Karolko, Bozena
    Mysiak, Andrzej
    Kubica, Jacek
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [9] COUMARIN THERAPY AND PLATELET AGGREGATION
    POLLER, L
    THOMSON, JM
    PRIEST, CM
    BRITISH MEDICAL JOURNAL, 1969, 1 (5642): : 474 - &
  • [10] Updated Report from an Emergency Department-Based Registry of NSTEMI Patients Given Upstream Advanced Oral Anti-Platelet Therapy
    Pollack, Charles, V
    Bhandary, Durgesh D.
    Frost, Alex
    Peacock, W. Frank
    Rao, Sunil, V
    Silber, Steven H.
    Diercks, Deborah B.
    DeRita, Renato
    Bhalla, Narinda
    Bangalore, Sripal
    Khan, Naeem D.
    CIRCULATION, 2018, 138
12345